Belvedere Trading’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Belvedere Trading’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,379	Closed	-$274K	–	1036
2025 Q1	$274K	Buy	+3,379	New	+$302K	﹤0.01%	288
2024 Q2	–	Sell	-4,986	Closed	-$473K	–	935
2024 Q1	$473K	Buy	+4,986	New	+$463K	﹤0.01%	164
2023 Q1	–	Sell	-2,537	Closed	-$211K	–	1487
2022 Q4	$211K	Buy	+2,537	New	+$205K	﹤0.01%	320

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Belvedere Trading's XBI Position: Q2 2025 in Review

Belvedere Trading sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2025, closing a stake of 3,379 shares — an estimated $274K sold.

Belvedere Trading first reported a position in XBI in Q4 2022 and held it in 3 quarters. The position peaked at $473K in Q1 2024. 625 funds tracked by Wall St. Rank hold XBI as of Q2 2025.

Belvedere Trading reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2025 after selling out during the quarter.
Belvedere Trading sold 3,379 State Street SPDR S&P Biotech ETF shares in Q2 2025, an estimated $274K.
Belvedere Trading first reported a position in State Street SPDR S&P Biotech ETF in Q4 2022 and held it in 3 quarters.
Belvedere Trading's State Street SPDR S&P Biotech ETF position peaked at $473K in Q1 2024.
625 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2025.

Based on Belvedere Trading's 13F filing for Q2 2025, filed 1 Aug 2025.